Quince Therapeutics, Inc. ( QNCX) - Key Metrics
QNCX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$12.31 | -$3.08 | -$3.08 |
| 2026Q1 | $0 | $143.37 | -$30.45 | -$30.45 |
| 2025Q4 | $0 | -$157.53 | -$41.84 | -$41.86 |
| 2025Q3 | $0 | -$49.83 | -$36.80 | -$37.08 |
| 2025Q2 | $0 | -$68.75 | -$48.90 | -$49.44 |
QNCX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -0.37 |
| 2026Q1 | 0% | 0.04 |
| 2025Q4 | 0% | -1.12 |
| 2025Q3 | 0% | -1.63 |
| 2025Q2 | 0% | -1.21 |
QNCX
Price: $33.93
52 week price:
Earnings Per Share: -210.00 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 34.7 million